
The episode discusses the implications of the FDA's compassionate use program in relation to Trump and an experimental drug.
This week on The Necessary Conversation, Chad, Haley, and Mary Lou discuss the biggest topics in politics. 💊 News broke that the FDA's "compassionate use" program — reserved for patients with serious or life-threatening conditions — was used to give a single 79-year-old man access to an unapproved experimental drug called Retatrutide. Trump was 79 when the request was made. The drug treats obesity, sleep apnea, and pulmonary hypertension — conditions that can be fatal in combination. The Whit...
Explore listener stats, chart rankings, contacts and more on the The Necessary Conversation podcast page.